kkklion.blogg.se

1. #AMBIFY REVIEW TRIAL#
2. #AMBIFY REVIEW DOWNLOAD#

#AMBIFY REVIEW TRIAL#

Participants with a smartphone, that is not compatible with the Abilify M圜ite® app will be offered a loaner phone for the trial period.

#AMBIFY REVIEW DOWNLOAD#

Participants must possess a smartphone and is familiar with its use and is willing to download and interact with the Abilify M圜ite® app.Male and female participants 18 to 65 years of age.Participants must be willing and able to give written informed consent, adhere to trial procedures and able to read and understand English.There was an interim analysis planned for the study. The trial will be conducted at 75 sites in the United States, 493 participants will be screened in order to enroll 320 participants and complete 224 participants. If deemed eligible to participate, participants will enter an open-label Abilify M圜ite® treatment prospective phase for up to 6 months.Īll participants who complete or withdraw from the trial while on Abilify M圜ite® will receive a telephone call for safety follow-up approximately 30 days after their last trial visit.

Participants will enter a screening period (up to 45 days). Participants must have had at least 1 inpatient psychiatric hospitalization within 4 years (48 months) and must have been prescribed oral antipsychotics for at least 6 months or longer prior to screening. This study is designed to assess the difference between inpatient psychiatric hospitalization rates in participants on oral standard-of-care antipsychotic treatment(s) for a period of 6 months followed by a switch to Abilify M圜ite® for a period of 3 months (Months 1 to 3).Īt the Month 3 visit, the investigator should decide if participants will continue on Abilify M圜ite® for an additional 3 months (Months 4 to 6) or switch to a standard-of-care treatment for the duration of treatment.